Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample
- 31 July 2007
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 9 (3), 305-314
- https://doi.org/10.2353/jmoldx.2007.060170
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancerHuman Pathology, 2007
- CpG Island Methylator Phenotype-Low (CIMP-Low) in Colorectal Cancer: Possible Associations with Male Sex and KRAS MutationsThe Journal of Molecular Diagnostics, 2006
- Senescence and serration: a new twist to an old taleThe Journal of Pathology, 2006
- Physical Activity and Survival After Colorectal Cancer DiagnosisJournal of Clinical Oncology, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Association of JC Virus T-Antigen Expression With the Methylator Phenotype in Sporadic Colorectal CancersGastroenterology, 2006
- CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instabilityGastroenterology, 2002
- Epigenetic patterns in the progression of esophageal adenocarcinoma.2001
- MethyLight: a high-throughput assay to measure DNA methylationNucleic Acids Research, 2000
- Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotypeProceedings of the National Academy of Sciences of the United States of America, 2000